GAMMA Investing
KPTI icon

GAMMA Investing’s Karyopharm Therapeutics KPTI Stock Holding History

GAMMA Investing’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.06K Buy
+865
New +$3.54K ﹤0.01% 4087

Other funds holding KPTI

TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Owl Creek Wealth Partners
Owl Creek Wealth Partners Denver, Colorado $355M AUM
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
MB, Levis & Associates
MB, Levis & Associates Center Valley, Pennsylvania $273M AUM 8.08% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
West Branch Capital
West Branch Capital Amherst, Massachusetts $442M AUM 32.59% 1-Year Est. Return

GAMMA Investing's KPTI Position: Q3 2026 in Review

GAMMA Investing opened a new position in Karyopharm Therapeutics (KPTI) in Q3 2026: 865 shares worth $1.06K. The stake represents ﹤0.01% of the portfolio and ranks #4087 among its holdings.

10 funds tracked by Wall St. Rank hold KPTI as of Q3 2026.

  • GAMMA Investing held 865 shares of Karyopharm Therapeutics worth $1.06K as of Q3 2026.
  • Karyopharm Therapeutics was a new GAMMA Investing position in Q3 2026.
  • Karyopharm Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4087 holding.
  • 10 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.